At the 2014 ACRO Annual Meeting, CTTI’s Executive Director Pamela Tenaerts spoke on the Innovation Panel. Comments focused on how increased patient involvement could be the disruptive change needed to improve the clinical trials system. Other experts featured on this panel included Patricia Leuchten, President and CEO of the Avoca Group Inc., Dalvir Gill, CEO of TransCelerate Biopharma, Luke Williams, professor of innovation and author of “Disrupt”, and John Lewis, Vice President of ACRO. The resulting speech was recorded and is now available online:

We’d like to thank ACRO for creating this video and sharing this message. At CTTI, patient engagement is at the core of several of our initiatives, such as the Patient Leadership Council, the Recruitment Project, and the Patient Groups & Clinical Trials Project. Through the collaboration of all stakeholders, including patients, we can move toward a high quality clinical trial system that is patient-centered and efficient, enabling reliable and timely access to evidence-based prevention and treatment options.